Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,798 INR | +1.58% | +5.68% | +8.56% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
Sales 2024 | 22.27B 267M | Sales 2025 * | 24.97B 299M | Capitalization | 232B 2.78B |
---|---|---|---|---|---|
Net income 2024 | 3.58B 42.84M | Net income 2025 * | 4.18B 50.12M | EV / Sales 2024 | 8.44 x |
Net cash position 2024 * | 7.68B 91.98M | Net cash position 2025 * | 10.03B 120M | EV / Sales 2025 * | 8.91 x |
P/E ratio 2024 |
52.6
x | P/E ratio 2025 * |
55.8
x | Employees | 4,048 |
Yield 2024 * |
0.6% | Yield 2025 * |
0.73% | Free-Float | 43.4% |
Latest transcript on Dr. Lal PathLabs Limited
1 day | +1.58% | ||
1 week | +5.68% | ||
Current month | +5.68% | ||
1 month | +20.48% | ||
3 months | +28.42% | ||
6 months | +4.01% | ||
Current year | +8.56% |
Managers | Title | Age | Since |
---|---|---|---|
Shankha Banerjee
CEO | Chief Executive Officer | - | 14-06-30 |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 05-12-31 |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 23-07-26 | |
Director/Board Member | 77 | 15-08-20 | |
Arvind Lal
CHM | Chairman | 74 | 95-02-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 6 M€ | +6.07% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 114 M€ | +4.36% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2,798 | +1.58% | 216,051 |
24-06-06 | 2,755 | -0.72% | 362,340 |
24-06-05 | 2,775 | +4.93% | 381,892 |
24-06-04 | 2,644 | -1.11% | 241,170 |
24-06-03 | 2,674 | +0.99% | 127,311 |
Delayed Quote NSE India S.E., June 07, 2024 at 07:58 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.56% | 2.74B | |
-22.13% | 7.91B | |
+76.16% | 4.52B | |
-2.80% | 2.66B | |
-50.41% | 2.02B | |
-19.59% | 1.68B | |
-20.07% | 1.51B | |
+19.31% | 1.24B | |
-45.78% | 1.1B | |
+20.02% | 1B |
- Stock Market
- Equities
- LALPATHLAB Stock